Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

The role of diagnostics in combatting life-threatening diseases

Article-The role of diagnostics in combatting life-threatening diseases

Join our upcoming webinar titled ‘Diagnose to prevent life-threatening diseases and enjoy a healthy lifestyle’, where we will explore how diagnostic solutions can help clinicians identify optimal treatment protocols.

Cardiac disease and diabetes mellitus are widespread in the Middle East and Africa. The health, wellness and well-being of the patients with those conditions are influenced by early diagnosis, prevention and optimal treatment.

Timely diagnosis allows for early intervention and treatment, which can significantly improve outcomes. Detecting diseases in the early stages provides an opportunity to implement appropriate medical interventions, lifestyle modifications, and preventive measures before the condition progresses to a life-threatening stage. Early diagnosis can enable medical professionals to develop targeted treatment plans, potentially leading to higher success rates and better long-term prognosis.

While battling the number one cause of death worldwide with cardiovascular disease testing, Beckman Coulter’s comprehensive cardiac lab tests include Access BNP, Access hsTnI, CK-MB and Myoglobin that can support care for patients before and after adverse cardiac events.

On the other hand, the diabetes menu of assays aids in the diagnosis of diabetes mellitus for the monitoring of long-term blood glucose control in individuals with diabetes mellitus and for identifying patients who may be at risk of developing this condition.

In an upcoming webinar titled ‘Diagnose to prevent life-threatening diseases and enjoy a healthy lifestyle’, Omnia Health will explore how these diagnostic solutions can help clinicians identify optimal treatment protocols and help support patient care.

The speakers will include Dr. Mazen Shaheen, Head of Cardiovascular Division CMC Hospital, Dubai, and Grace Estephan, Marketing Communications Manager at Beckman Coulter, who will moderate the event.

on24_registration_page_banner.png

The objectives of this webinar would be to underline the need for a comprehensive testing panel for cardiac diseases, the importance of early and comprehensive screening of diabetes mellitus, and the impact of optimal diagnosis on clinicians’ treatment approaches, patients’ quality of life and healthcare systems.

The webinar will take place on July 26 at 2:30 pm GST. To learn more or to register, click here.

Back to Laboratory

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish